172 related articles for article (PubMed ID: 38233507)
1. Secretomics reveals hormone-therapy of breast cancer may induce survival by facilitating hypercoagulation and immunomodulation in vitro.
Augustine TN; Buthelezi S; Pather K; Xulu KR; Stoychev S
Sci Rep; 2024 Jan; 14(1):1486. PubMed ID: 38233507
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation.
Xulu KR; Augustine TN
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923802
[TBL] [Abstract][Full Text] [Related]
3. Modelling the procoagulatory effect of Anastrozole relative to ERα and ERβ expression in breast cancer cells.
Pather K; Augustine TN
J Thromb Thrombolysis; 2022 Oct; 54(3):401-410. PubMed ID: 35932382
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer cell-induced platelet activation is compounded by tamoxifen and anastrozole in vitro.
Pather K; Dix-Peek T; Duarte R; Chetty N; Augustine TN
Thromb Res; 2019 May; 177():51-58. PubMed ID: 30851629
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
6. The influence of platelet membranes on tumour cell behaviour.
Coupland LA; Hindmarsh EJ; Gardiner EE; Parish CR
Cancer Metastasis Rev; 2017 Jun; 36(2):215-224. PubMed ID: 28707200
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Cells Induce a Pro-inflammatory Response to Mitigate Immune Mediation in a 3D Culture Model.
Augustine TN; Duarte R; Candy GP
Anticancer Res; 2020 Nov; 40(11):6179-6193. PubMed ID: 33109555
[TBL] [Abstract][Full Text] [Related]
8. STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer.
Cavalcante RS; Ishikawa U; Silva ES; Silva-Júnior AA; Araújo AA; Cruz LJ; Chan AB; de Araújo Júnior RF
Br J Pharmacol; 2021 Jun; 178(11):2284-2304. PubMed ID: 33434950
[TBL] [Abstract][Full Text] [Related]
9. PYK2 promotes HER2-positive breast cancer invasion.
Al-Juboori SI; Vadakekolathu J; Idri S; Wagner S; Zafeiris D; Pearson JR; Almshayakhchi R; Caraglia M; Desiderio V; Miles AK; Boocock DJ; Ball GR; Regad T
J Exp Clin Cancer Res; 2019 May; 38(1):210. PubMed ID: 31118051
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling.
Wen S; Hou Y; Fu L; Xi L; Yang D; Zhao M; Qin Y; Sun K; Teng Y; Liu M
Cancer Lett; 2019 Feb; 442():320-332. PubMed ID: 30391782
[TBL] [Abstract][Full Text] [Related]
11.
Augustine TN; Pather K; Mak D; Klonaros D; Xulu K; Dix-Peek T; Duarte R; van der Spuy WJ
Ultrastruct Pathol; 2020 May; 44(3):262-272. PubMed ID: 32252581
[TBL] [Abstract][Full Text] [Related]
12. The role of epithelial-mesenchymal transition in cancer pathology.
Guarino M; Rubino B; Ballabio G
Pathology; 2007 Jun; 39(3):305-18. PubMed ID: 17558857
[TBL] [Abstract][Full Text] [Related]
13. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
[TBL] [Abstract][Full Text] [Related]
14. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts.
Olsen CJ; Moreira J; Lukanidin EM; Ambartsumian NS
BMC Cancer; 2010 Aug; 10():444. PubMed ID: 20723242
[TBL] [Abstract][Full Text] [Related]
15. Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression.
Holliday DL; Brouilette KT; Markert A; Gordon LA; Jones JL
Breast Cancer Res; 2009; 11(1):R3. PubMed ID: 19152687
[TBL] [Abstract][Full Text] [Related]
16. Secretome identification of immune cell factors mediating metastatic cell homing.
Aguado BA; Wu JJ; Azarin SM; Nanavati D; Rao SS; Bushnell GG; Medicherla CB; Shea LD
Sci Rep; 2015 Dec; 5():17566. PubMed ID: 26634905
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inter-clonal cooperation involving crosstalk, co-option and co-dependency can enhance the invasiveness of genetically distant cancer clones.
Carneiro CS; Hapeman JD; Nedelcu AM
BMC Ecol Evol; 2023 May; 23(1):20. PubMed ID: 37226092
[TBL] [Abstract][Full Text] [Related]
18. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
Shen J; Cao B; Wang Y; Ma C; Zeng Z; Liu L; Li X; Tao D; Gong J; Xie D
J Exp Clin Cancer Res; 2018 Jul; 37(1):175. PubMed ID: 30055645
[TBL] [Abstract][Full Text] [Related]
19. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
[TBL] [Abstract][Full Text] [Related]
20. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
